[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fW2E6D-Bt9hwcAIn8zUbUufVwTP_CXVYdAPuCqbahN_c":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":55,"rows":62},"University of Connecticut",[4],130,false,25,0,29216,4,122,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Obesity",16,{"name":18,"count":19},"Hyperthermia",7,{"name":21,"count":22},"Hypertension",6,{"name":24,"count":22},"HIV Prevention Program",{"name":26,"count":27},"Weight Loss",5,{"name":29,"count":27},"Cardiovascular Diseases",{"name":31,"count":11},"HIV",{"name":33,"count":11},"Cardiovascular Disease",[35,40,45,50],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05700916","Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity","2026-05","Milk Polar Lipid-Rich Dairy Powder",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT05283382","Cannabidiol Effects on Learning and Anxiety","2026-12-30","Cannabidiol Oral Product",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT05669534","Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP","2027-01","Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT07365514","Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females","2028-02","Blackcurrant (BC) extract",[56,57,58,59,60,61],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[63,88,126,148,169,194,220],{"intervention":49,"totalTrials":64,"cells":65},1,{"EARLY_PHASE1":66,"PHASE1":68,"PHASE2":70,"PHASE3":72,"PHASE4":74,"NA":86},{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":9},[],{"trials":71,"activeCount":9},[],{"trials":73,"activeCount":9},[],{"trials":75,"activeCount":64,"soonestReadout":48},[76],{"nctId":46,"briefTitle":47,"status":77,"phases":78,"primaryCompletion":48,"completion":79,"start":80,"enrollment":81,"conditions":82,"interventions":85},"RECRUITING",[60],"2027-01-01","2023-03-01",256,[83,84],"Hiv","Opioid Use Disorder",[49],{"trials":87,"activeCount":9},[],{"intervention":89,"totalTrials":90,"cells":91},"blackcurrant (BC) extract",2,{"EARLY_PHASE1":92,"PHASE1":94,"PHASE2":118,"PHASE3":120,"PHASE4":122,"NA":124},{"trials":93,"activeCount":9},[],{"trials":95,"activeCount":64,"soonestReadout":53},[96,108],{"nctId":97,"briefTitle":98,"status":99,"phases":100,"primaryCompletion":101,"completion":101,"start":102,"enrollment":103,"conditions":104,"interventions":107},"NCT04431960","Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk","COMPLETED",[57],"2022-10-03","2021-07-20",51,[105,106,29],"Postmenopausal Osteoporosis","Gut Microbiota",[89],{"nctId":51,"briefTitle":52,"status":109,"phases":110,"primaryCompletion":53,"completion":111,"start":112,"enrollment":113,"conditions":114,"interventions":117},"NOT_YET_RECRUITING",[57],"2029-09","2026-02-01",159,[105,115,116],"Gut Microbiome","Menopause",[54,54],{"trials":119,"activeCount":9},[],{"trials":121,"activeCount":9},[],{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"intervention":44,"totalTrials":64,"cells":127},{"EARLY_PHASE1":128,"PHASE1":138,"PHASE2":140,"PHASE3":142,"PHASE4":144,"NA":146},{"trials":129,"activeCount":64,"soonestReadout":43},[130],{"nctId":41,"briefTitle":42,"status":77,"phases":131,"primaryCompletion":43,"completion":132,"start":133,"enrollment":134,"conditions":135,"interventions":137},[56],"2027-02","2024-10-30",160,[136],"Anxiety and Fear",[44],{"trials":139,"activeCount":9},[],{"trials":141,"activeCount":9},[],{"trials":143,"activeCount":9},[],{"trials":145,"activeCount":9},[],{"trials":147,"activeCount":9},[],{"intervention":39,"totalTrials":64,"cells":149},{"EARLY_PHASE1":150,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":167},{"trials":151,"activeCount":64,"soonestReadout":38},[152],{"nctId":36,"briefTitle":37,"status":77,"phases":153,"primaryCompletion":38,"completion":154,"start":155,"enrollment":6,"conditions":156,"interventions":158},[56],"2026-06","2023-10-20",[157,15],"Dyslipidemias",[39],{"trials":160,"activeCount":9},[],{"trials":162,"activeCount":9},[],{"trials":164,"activeCount":9},[],{"trials":166,"activeCount":9},[],{"trials":168,"activeCount":9},[],{"intervention":170,"totalTrials":64,"cells":171},"Leuprolide acetate",{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":192},{"trials":173,"activeCount":9},[],{"trials":175,"activeCount":9},[],{"trials":177,"activeCount":9},[],{"trials":179,"activeCount":9},[],{"trials":181,"activeCount":9},[182],{"nctId":183,"briefTitle":184,"status":99,"phases":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":191},"NCT00349258","The Use of GnRH Agonist Trigger in the Prevention of OHSS",[60],"2006-05","2004-08",66,[190],"Ovarian Hyperstimulation Syndrome",[170],{"trials":193,"activeCount":9},[],{"intervention":195,"totalTrials":64,"cells":196},"Heat Shock Protein 70 HSP70",{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":218},{"trials":198,"activeCount":9},[],{"trials":200,"activeCount":9},[201],{"nctId":202,"briefTitle":203,"status":99,"phases":204,"completion":205,"start":206,"enrollment":207,"conditions":208,"interventions":211},"NCT00027144","Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase",[57],"2002-10","2000-12",10,[209,210],"Leukemia,Myeloid, Chronic","Leukemia,Myeloid,Philadelphia-Positive",[195],{"trials":213,"activeCount":9},[],{"trials":215,"activeCount":9},[],{"trials":217,"activeCount":9},[],{"trials":219,"activeCount":9},[],{"intervention":221,"totalTrials":64,"cells":222},"risperidone",{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":227,"PHASE3":229,"PHASE4":231,"NA":233},{"trials":224,"activeCount":9},[],{"trials":226,"activeCount":9},[],{"trials":228,"activeCount":9},[],{"trials":230,"activeCount":9},[],{"trials":232,"activeCount":9},[],{"trials":234,"activeCount":9},[235],{"nctId":236,"briefTitle":237,"status":238,"phases":239,"completion":240,"start":241,"conditions":242,"interventions":245},"NCT00203775","Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates","TERMINATED",[61],"2004-04","2002-07",[243,244],"Psychosis","Aggression",[221]]